Cross-protection among unrelated Leptospira pathogens serovars: An unfinished story

Advances in Clinical and Experimental Medicine

Volumn 21, Issue 5, 2012, Pages 581-589

  Rosario, Luis A ^a   Arencibia, Daniel F ^b   Suarez, Yolanda E ^a   Infante, Juan F ^b   Valdés, Bárbara Y ^b   Batista, Niurka ^b  

^a UNIVERSITY OF HAVANA   (Cuba)

^b FINLAY INSTITUTE   (Cuba)

Author keywords

Cross protection; Leptospira; Leptospirosis; Mesocricetus auratus; Vaccine

Indexed keywords

LEPTOSPIROSIS VACCINE; UNCLASSIFIED DRUG; VAX SPIRAL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SCREENING; ARTICLE; AUTOPSY; BACTERIAL STRAIN; BACTERIUM CULTURE; CROSS PROTECTION; HAMSTER; HISTOPATHOLOGY; LD 50; LEPTOSPIRA; NONHUMAN; PATHOGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION; SEROTYPE; VACCINE PRODUCTION;

EID: 84870323931     PISSN: 18995276     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Vinetz JM: Leptospirosis. Curr Opin Infect Dis 2001, 14, 527-538.
2. Trueba G, Zapata S, Madrid K, Cullen P, Haake D: Cell aggregation: a mechanism of pathogenic Leptospira to survive in fresh water. Int Microbiol 2004, 7, 35-40.
3. Waitkins SA: Leptospirosis as an occupational disease. Br J Ind Med 1986, 43, 721-725.
4. McBride AJ, Athanazio DA, Reis MG, Ko AI: Leptospirosis. Curr Opin Infect Dis 2005, 18, 376-386.
5. Adler B, de la Peńa M: Leptospira and Leptospirosis. Vet Microbiol 2009, 2, 4382-4392.
6. Faine S, Adler B, Bolin C, Perolat P: Leptospira and leptospirosis. Medisci Melbourne 1999, 135-165.
7. Kuriakose M, Eapen CK, Paul R: Leptospirosis in Kolenchery, Kerala, India: epidemiology, prevalent local serogroups and serovars and a new serovar. Eur J Epidemiol 1997, 13, 691-697.
8. Gravekamp C, Van De Kemp H, Franzen M, Carrington D, Schoone GJ, Van Eys GJJM: Detection of seven species of pathogenic leptospiras by PCR using two sets of primers. J Gen Microbiol 1993, 139, 1691-1700.
9. Faine S: Leptospira and leptospirosis, CRC Press, Boca Raton [FL], 1994.
10. Jost BH, Adler B, Vinh T, Faine S: A monoclonal antibody reacting with a determinant on leptospiral lipopolysaccharide protects guinea pigs against leptospirosis. J Med Microbiol 1986, 22, 269-275.
11. Levett PN: Leptospirosis. Clin Microbiol Rev 2001, 14, 296-326.
12. Cinco M, Domenis R, Perticarari S, Presani G, Marangoni A, Blasi E: Interaction of leptospiras with murine microglial cells. New Microbiol 2006, 29[3], 193-199.
13. Sonrier C, Branger C, Michel V, Ruvoen-Clouet N, Ganiere JP, Andre-Fontaine G: Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine 2001, 19[1], 86-94.
14. Silva EF, Medieros MA, Mc Bride AJA, Matasunga J, Esteves GS, Ramos JGR: The terminal portion of leptospiral immunoglobulin-like protein Lig A confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 2007, 25[33], 6277-6286.
15. Silva E, Santo C, Athanazio D, Seyffert N, Seixas F, Cerqueira GM: Characterization of virulent Leptospira isolates in hamster model. Vaccine 2008, 26, 3892-3896.
16. Reed LJ, Muench H: A simple method of estimation fifty percent end-points. Am J Hyg 1938, 27, [3], 493-497.
17. Finlay Institute: Sanitary Registration of vax-SPIRAL (trivalent antileptospirosic vaccine), 1998, 23-25.
18. González A, Rodríguez Y, Batista N, Valdés Y, Núńez JF, González M: Booster effect of an active immunization with Leptospira interrogans serogroup Ballum in hamsters vaccinated with vax-SPIRAL. VacciMonitor 2003, 12[2], 1-6.
19. KIT Biomedical Research. International Course on Laboratory Methods for the Diagnosis of Leptospirosis. Amsterdam: Royal Tropical Institute; 2006.
20. Falkow S: Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 1988, 10[2], 274-276.
21. Hem A, Smith AJ, Solberg P: Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret, and mink. Lab Animal 1998; 32, [4], 364-368.
22. Cole JR, Sulzer CR, Pursell AR: Improved microtechnique for the leptospiral microscopic agglutination test. Appl Microbiol 1973, 25, 979-980.
23. Oliva R, Infante J, González M, González I, Farinás M: Clinical and pathological characterization of leptospirosis in Golden Syrian hamster and Duncan Hartley guinea pig by means of experimental infection with three L. interrogans serovars. VacciMonitor 1998, 7[5], 8-13.
24. Matsunaga J, Young T, Barnett J, Barnett D, Bolin C, Haake D: Novel 45-kilodalton leptospiral protein that is processed to a 31-kilodalton growth-phase-regulated peripheral membrane protein. Infect Immun 2002, 70[1], 323-334.
25. Barnett J, Barnett D, Bolin C, Summers T, Wagar E, Cheville N: Expression and distribution of leptospiral outer membrane components during renal infection of hamsters. Infect Immun 1999, 67, 853-861.
26. Merien F, Truccolo J, Baranton G, Perolat P: Identification of a 36-kDa fibronectin-binding protein expressed by a virulent variant of Leptospira interrogans serovar Icterohaemorrhagiae. FEMS Microbiol Lett 2000, 185, 17-22.
27. Merien F, Baranton G, Perolat P: Invasion of Vero cells and induction of apoptosis in macrophages by pathogenic Leptospira interrogans are correlated with virulence. Infect Immun 1997, 65[2], 729-738.
28. Suepaul SM, Carringtonb CV, Campbell M, Bordea G, Adesiyuna AA: Study on the efficacy of Leptospira vaccines developed from serovars isolated from Trinidad and comparison with commercial vaccines using a hamster model. Vaccine 2010, 28 [1], 5421-5426.
29. Chapman A, Everard COR, Faine S, Adler B: Antigens recognized by the human immune response to severe leptospirosis in Barbados. Epidemiol Infect 1991, 107, 143-155.
30. Biswas D, Roy S, Vijayachari P, Sugunan A, Nararajaseenivasan K, Sehgal S: Comparison of immunoreactive proteins of commonly circulating serogroups of Leptospira in Andaman Islands. India J Med Res 2005, 121, 151-158.